Example of Current HIV/AIDS Reports format
Recent searches

Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format Example of Current HIV/AIDS Reports format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Current HIV/AIDS Reports — Template for authors

Publisher: Springer
Categories Rank Trend in last 3 yrs
Infectious Diseases #67 of 288 down down by 51 ranks
Virology #26 of 69 down down by 19 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 180 Published Papers | 1073 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 06/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

Springer

Quality:  
High
CiteRatio: 6.0
SJR: 1.026
SNIP: 1.34
open access Open Access

Elsevier

Quality:  
High
CiteRatio: 5.9
SJR: 1.175
SNIP: 1.033
open access Open Access
recommended Recommended

Elsevier

Quality:  
High
CiteRatio: 23.9
SJR: 4.491
SNIP: 3.727
open access Open Access

Elsevier

Quality:  
High
CiteRatio: 6.5
SJR: 1.43
SNIP: 1.356

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

6.0

8% from 2019

CiteRatio for Current HIV/AIDS Reports from 2016 - 2020
Year Value
2020 6.0
2019 6.5
2017 10.3
2016 7.3
graph view Graph view
table view Table view

2.135

10% from 2019

SJR for Current HIV/AIDS Reports from 2016 - 2020
Year Value
2020 2.135
2019 1.942
2017 2.645
2016 1.889
graph view Graph view
table view Table view

1.267

1% from 2019

SNIP for Current HIV/AIDS Reports from 2016 - 2020
Year Value
2020 1.267
2019 1.253
2017 1.377
2016 1.153
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has decreased by 8% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has increased by 10% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 1% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Current HIV/AIDS Reports

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Springer

Current HIV/AIDS Reports

Approved by publishing and review experts on SciSpace, this template is built as per for Current HIV/AIDS Reports formatting guidelines as mentioned in Springer author instructions. The current version was created on and has been used by 217 authors to write and format their manuscripts to this journal.

i
Last updated on
05 Jul 2020
i
ISSN
1606-8610
i
Open Access
Hybrid
i
Sherpa RoMEO Archiving Policy
White faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Citation Type
Author Year
(Blonder et al, 1982)
i
Bibliography Example
Beenakker CWJ (2006) Specular andreev reflection in graphene. Phys Rev Lett 97(6):067,007, URL 10.1103/PhysRevLett.97.067007

Top papers written in this journal

Journal Article DOI: 10.1007/S11904-012-0118-8
HIV and inflammation: mechanisms and consequences.
Peter W. Hunt1

Abstract:

Persistent immune activation and inflammation despite sustained antiretroviral therapy (ART)-mediated viral suppression has emerged as a major challenge of the modern HIV treatment era. While immune activation, inflammatory, and coagulation markers typically decline during suppressive ART, they remain abnormally elevated in m... Persistent immune activation and inflammation despite sustained antiretroviral therapy (ART)-mediated viral suppression has emerged as a major challenge of the modern HIV treatment era. While immune activation, inflammatory, and coagulation markers typically decline during suppressive ART, they remain abnormally elevated in many HIV-infected individuals and predict subsequent mortality and non-AIDS morbidities including cardiovascular disease. The goal of this review is to summarize the current state of our knowledge regarding the underlying causes of persistent immune activation during ART-mediated viral suppression as well as the link between persistent immune activation and morbidity and mortality in this setting. Several recent studies have linked surrogate markers of this persistent inflammatory state to clinical outcomes, validating persistent immune activation as a viable therapeutic target. Other recent studies have helped clarify the roles of persistent HIV expression and/or replication, microbial translocation, and co-infections in driving this persistent inflammatory state, identifying targets for novel interventions. read more read less
331 Citations
open accessOpen access Journal Article DOI: 10.1007/S11904-014-0220-1
Depression and Adherence to Antiretroviral Therapy in Low-, Middle- and High-Income Countries: A Systematic Review and Meta-Analysis

Abstract:

We investigated the associations between depres- sive symptoms and adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV). We searched the PubMed, EMBASE and Cochrane CENTRAL databases for studies that reported an association between depression and adherence to ART as a primary or second- ary outcome. ... We investigated the associations between depres- sive symptoms and adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV). We searched the PubMed, EMBASE and Cochrane CENTRAL databases for studies that reported an association between depression and adherence to ART as a primary or second- ary outcome. We used a random-effect model to pool the risk estimates from the individual studies. The odds ratio (OR) with their 95 % CIs were used as summary estimates. Of 2861 citations, 111 studies that recruited 42,366 PLHIV met our inclusion criteria. When reported, the rate of PLHIV with depressive symptoms ranged from 12.8 to 78 % and the proportion of PLHIV who achieved good adherence (≥80 %) ranged from 20 to 98 %. There were no significant differences in rate of depressive symptoms in PLHIV by country income group; however, the proportion of PLHIV who achieved good adherence was significantly higher in lower-income countries (as defined in the 2012 World Bank Country Income Groups) (pooled rate=86 %) compared to higher-income countries (pooled rate=67.5 %; p<.05). We found that the likelihood of achieving good ART adherence was 42 % lower among those with depres- sive symptoms compared to those without (pooled OR= 0.58, 95 % CI 0.55 to 0.62). The relationship between depressive symptoms and adherence to ART was consistent across the country's income group, study design and ad- herence rates. We found that the magnitude of the associ- ation significantly decreases with more recent publications and increasing study sample size. The higher the preva- lence of depressive symptoms of PLHIV recruited in the studies, the lower the likelihood of achieving good adher- ence to ART. In conclusion, the likelihood of achieving good adherence was lower among those with depressive symptoms compared to those without. O. A. U. and J. M. contributed equally to this work and fulfilled the criteria of joint first authorship. read more read less
View PDF
323 Citations
Journal Article DOI: 10.1007/S11904-010-0041-9
HIV and Aging: Time for a New Paradigm
Amy C. Justice1

Abstract:

The population of patients with HIV infection achieving viral suppression on combination antiretroviral therapy is growing, aging, and experiencing a widening spectrum of non-AIDS diseases. Concurrently, AIDS-defining conditions are becoming less common and are variably associated with outcome. Nonetheless, the spectrum of di... The population of patients with HIV infection achieving viral suppression on combination antiretroviral therapy is growing, aging, and experiencing a widening spectrum of non-AIDS diseases. Concurrently, AIDS-defining conditions are becoming less common and are variably associated with outcome. Nonetheless, the spectrum of disease experienced by those aging with HIV remains strongly influenced by HIV, its treatment, and the behaviors, conditions, and demographics associated with HIV infection. Our focus must shift from a narrow interest in CD4 counts, HIV-RNA, and AIDS-defining illnesses to determining the optimal management of HIV infection as a complex chronic disease in which the causes of morbidity and mortality are multiple and overlapping. We need a new paradigm of care with which to maximize functional status, minimize frailty, and prolong life expectancy. A composite index that summarizes a patient’s risk of morbidity and mortality could facilitate this work and help chart its progress. read more read less

Topics:

Population (52%)52% related to the paper, Disease (51%)51% related to the paper
View PDF
305 Citations
Journal Article DOI: 10.1007/S11904-008-0025-1
HIV and depression: 2008 review and update
Judith G. Rabkin1

Abstract:

Since the earliest days of the AIDS epidemic, clinicians have been concerned about the prevalence of depression among their patients. Epidemiologists, psychiatrists, psychologists, sociologists, and a broad array of other specialists have studied this topic, trying to determine the prevalence of depressive disorders and depre... Since the earliest days of the AIDS epidemic, clinicians have been concerned about the prevalence of depression among their patients. Epidemiologists, psychiatrists, psychologists, sociologists, and a broad array of other specialists have studied this topic, trying to determine the prevalence of depressive disorders and depressive symptoms as well as antecedents, correlates, and consequences. This review addresses the methodologic difficulties in determining depression prevalence, major findings regarding rates of disorder and correlates among different segments of the HIV community, effects of depression on HIV illness progression, psychopharmacologic and psychotherapeutic treatment findings, and behavioral effects of depression, such as its impact on medication adherence, employment, and risk behavior. Finally, the article summarizes international studies of depression prevalence in developing countries and the challenges regarding cross-national diagnostic definitions and measures. read more read less

Topics:

Depression (differential diagnoses) (53%)53% related to the paper, Acquired immunodeficiency syndrome (AIDS) (52%)52% related to the paper
View PDF
303 Citations
open accessOpen access Journal Article DOI: 10.1007/S11904-009-0030-Z
Food insecurity and HIV/AIDS: current knowledge, gaps, and research priorities.

Abstract:

Food insecurity and HIV/AIDS are intertwined in a vicious cycle that heightens vulnerability to, and worsens the severity of, each condition. We review current knowledge and research priorities regarding the impact of food insecurity on HIV transmission risk and clinical outcomes. Observational studies suggest that food insec... Food insecurity and HIV/AIDS are intertwined in a vicious cycle that heightens vulnerability to, and worsens the severity of, each condition. We review current knowledge and research priorities regarding the impact of food insecurity on HIV transmission risk and clinical outcomes. Observational studies suggest that food insecurity is associated with increased HIV transmission risk behaviors and decreased access to HIV treatment and care. Among individuals receiving antiretroviral therapy (ART), food insecurity is associated with decreased ART adherence, reduced baseline CD4 cell count, incomplete virologic suppression, and decreased survival. Integration of food security interventions into HIV/AIDS treatment programs is essential to curtail the HIV/AIDS epidemic and improve health and quality of life among those infected. Longitudinal research applying validated measurement tools is needed to better understand the mechanisms through which food insecurity adversely impacts HIV transmission, treatment, and care. Research should compare the effectiveness of various food assistance and livelihood strategies. read more read less

Topics:

Acquired immunodeficiency syndrome (AIDS) (56%)56% related to the paper, Food security (56%)56% related to the paper
View PDF
296 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Current HIV/AIDS Reports.

It automatically formats your research paper to Springer formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Current HIV/AIDS Reports in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Current HIV/AIDS Reports guidelines and auto format it.

2. Do you follow the Current HIV/AIDS Reports guidelines?

Yes, the template is compliant with the Current HIV/AIDS Reports guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Current HIV/AIDS Reports?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Current HIV/AIDS Reports citation style.

4. Can I use the Current HIV/AIDS Reports templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Current HIV/AIDS Reports.

5. Can I use a manuscript in Current HIV/AIDS Reports that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Current HIV/AIDS Reports that you can download at the end.

6. How long does it usually take you to format my papers in Current HIV/AIDS Reports?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Current HIV/AIDS Reports.

7. Where can I find the template for the Current HIV/AIDS Reports?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Current HIV/AIDS Reports's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Current HIV/AIDS Reports's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Current HIV/AIDS Reports an online tool or is there a desktop version?

SciSpace's Current HIV/AIDS Reports is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Current HIV/AIDS Reports?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Current HIV/AIDS Reports?”

11. What is the output that I would get after using Current HIV/AIDS Reports?

After writing your paper autoformatting in Current HIV/AIDS Reports, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Current HIV/AIDS Reports's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Current HIV/AIDS Reports?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Current HIV/AIDS Reports. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Current HIV/AIDS Reports?

The 5 most common citation types in order of usage for Current HIV/AIDS Reports are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Current HIV/AIDS Reports?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Current HIV/AIDS Reports's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Current HIV/AIDS Reports in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Current HIV/AIDS Reports Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Current HIV/AIDS Reports formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template